Literature DB >> 15911628

The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation.

Claudia Esser1, Martin Scheffner, Jörg Höhfeld.   

Abstract

The cellular level of the tumor suppressor p53 is tightly regulated through induced degradation via the ubiquitin/proteasome system. The ubiquitin ligase Mdm2 plays a pivotal role in stimulating p53 turnover. However, recently additional ubiquitin ligases have been identified that participate in the degradation of the tumor suppressor. Apparently, multiple degradation pathways are employed to ensure proper destruction of p53. Here we show that the chaperone-associated ubiquitin ligase CHIP is able to induce the proteasomal degradation of p53. CHIP-induced degradation was observed for mutant p53, which was previously shown to associate with the chaperones Hsc70 and Hsp90, and for the wild-type form of the tumor suppressor. Our data reveal that mutant and wild-type p53 transiently associate with molecular chaperones and can be diverted onto a degradation pathway through this association.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911628     DOI: 10.1074/jbc.M501574200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  112 in total

1.  SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.

Authors:  D Li; N D Marchenko; U M Moll
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.

Authors:  Jing Nie; Ping Xie; Lin Liu; Guichun Xing; Zhijie Chang; Yuxin Yin; Chunyan Tian; Fuchu He; Lingqiang Zhang
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

Review 3.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

4.  Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP.

Authors:  Vikram Narayan; Emmanuelle Pion; Vivien Landré; Petr Müller; Kathryn L Ball
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

5.  Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor.

Authors:  Chang-Hoon Woo; Nhat-Tu Le; Tetsuro Shishido; Eugene Chang; Hakjoo Lee; Kyung-Sun Heo; Deanne M Mickelsen; Yan Lu; Carolyn McClain; Thomas Spangenberg; Chen Yan; Carlos A Molina; Jay Yang; Cam Patterson; Jun-ichi Abe
Journal:  FASEB J       Date:  2010-08-19       Impact factor: 5.191

6.  Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.

Authors:  Long Chen; Jie Li; Elia Farah; Sukumar Sarkar; Nihal Ahmad; Sanjay Gupta; James Larner; Xiaoqi Liu
Journal:  Mol Cancer Ther       Date:  2016-07-07       Impact factor: 6.261

Review 7.  Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.

Authors:  Mu-Shui Dai; Yetao Jin; Jayme R Gallegos; Hua Lu
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

8.  Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90) in vitro.

Authors:  J Luis Morales; Gary H Perdew
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

9.  Ubiquitination and degradation of mutant p53.

Authors:  Natalia Lukashchuk; Karen H Vousden
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

10.  CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation.

Authors:  Ping Xie; Yongna Fan; Hua Zhang; Yuan Zhang; Mingpeng She; Dongfeng Gu; Cam Patterson; Huihua Li
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.